DOI:
10.1055/s-00032099
Planta Medica International Open
LinksClose Window
References
Garcia-Recio S, Fuster G, Fernandez-Nogueira P, Pastor-Arroyo EM, Park SY, Mayordomo C, Ametller E, Mancino M, Gonzalez-Farre X, Russnes HG, Engel P, Costamagna D, Fernandez PL, Gascón P, Almendro V.
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.
Cancer Res 2013;
73: 6424-6434
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.